CA2228503A1 - Use of griseofulvin for inhibiting the growth of cancers - Google Patents

Use of griseofulvin for inhibiting the growth of cancers Download PDF

Info

Publication number
CA2228503A1
CA2228503A1 CA002228503A CA2228503A CA2228503A1 CA 2228503 A1 CA2228503 A1 CA 2228503A1 CA 002228503 A CA002228503 A CA 002228503A CA 2228503 A CA2228503 A CA 2228503A CA 2228503 A1 CA2228503 A1 CA 2228503A1
Authority
CA
Canada
Prior art keywords
agents
composition according
pharmaceutical composition
griseofulvin
tumors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002228503A
Other languages
English (en)
French (fr)
Inventor
James Berger Camden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2228503A1 publication Critical patent/CA2228503A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002228503A 1995-08-03 1996-07-30 Use of griseofulvin for inhibiting the growth of cancers Abandoned CA2228503A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US183995P 1995-08-03 1995-08-03
US60/001,839 1995-08-03
US67418196A 1996-07-16 1996-07-16
US08/674,181 1996-07-16

Publications (1)

Publication Number Publication Date
CA2228503A1 true CA2228503A1 (en) 1997-02-20

Family

ID=26669547

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002228503A Abandoned CA2228503A1 (en) 1995-08-03 1996-07-30 Use of griseofulvin for inhibiting the growth of cancers

Country Status (16)

Country Link
EP (1) EP0841914A2 (xx)
JP (1) JPH11511136A (xx)
KR (1) KR19990036137A (xx)
AR (1) AR003176A1 (xx)
AU (1) AU713031B2 (xx)
BR (1) BR9609920A (xx)
CA (1) CA2228503A1 (xx)
CZ (1) CZ30598A3 (xx)
HU (1) HUP9903506A3 (xx)
IL (1) IL123094A0 (xx)
MX (1) MX9800945A (xx)
NO (1) NO980420L (xx)
PL (1) PL324905A1 (xx)
SK (1) SK14298A3 (xx)
TR (1) TR199800244T2 (xx)
WO (1) WO1997005870A2 (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
DK1098641T3 (en) * 1998-07-27 2016-08-15 St Jude Pharmaceuticals Inc Chemically induced intracellular hyperthermia
DK1616572T3 (da) * 1998-11-09 2010-12-06 Biogen Idec Inc Kimært anti-CD20-antistof, rituxan, til anvendelse i behandling af kronisk lymfatisk leukæmi
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
ATE489080T1 (de) * 2001-06-25 2010-12-15 Ajinomoto Kk Antitumorale mittel
EP2008652A1 (en) * 2007-06-28 2008-12-31 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering
EP2204367A1 (en) * 2008-12-22 2010-07-07 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering

Also Published As

Publication number Publication date
IL123094A0 (en) 1998-09-24
AU6683496A (en) 1997-03-05
JPH11511136A (ja) 1999-09-28
HUP9903506A3 (en) 2000-07-28
HUP9903506A2 (hu) 2000-06-28
TR199800244T2 (xx) 1998-09-21
MX9800945A (es) 1998-04-30
CZ30598A3 (cs) 1998-06-17
AU713031B2 (en) 1999-11-18
NO980420L (no) 1998-04-03
PL324905A1 (en) 1998-06-22
NO980420D0 (no) 1998-01-30
WO1997005870A2 (en) 1997-02-20
KR19990036137A (ko) 1999-05-25
EP0841914A2 (en) 1998-05-20
AR003176A1 (es) 1998-07-08
WO1997005870A3 (en) 1997-04-17
BR9609920A (pt) 1999-07-06
SK14298A3 (en) 1998-09-09

Similar Documents

Publication Publication Date Title
CA2228503A1 (en) Use of griseofulvin for inhibiting the growth of cancers
EP0821586B1 (en) A pharmaceutical composition containing benzimidazole for inhibiting the growth of cancers
AU714057B2 (en) A pharmaceutical composition containing N-phosphonoglycine derivatives for inhibiting the growth of viruses and cancers
AU711966B2 (en) Use of fluconazole for inhibiting the growth of cancers
US5929099A (en) Pharmaceutical composition for inhibiting the growth of cancers
CA2217953C (en) A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers
MXPA98000998A (en) Use of fluconazole to inhibit the growth of cance
WO1998051303A1 (en) Hiv and cancer treatment
US6110953A (en) Pharmaceutical composition for inhibiting the growth of cancers
MXPA98000945A (en) Use of griseofulvine to inhibit cancer growth
KR100424503B1 (ko) 암전이억제제
US5908855A (en) Compositions for treating viral infections
MXPA98000944A (es) Uso de derivados de 1h-1,2,4-triazol para inhibirel crecimiento de canceres
US20010041678A1 (en) Compositions and methods for treating cancer
EP2931375B1 (de) Verwendung von wirkstoffkombinationen zur induktion einer tumorseneszenz
AU730920B2 (en) A pharmaceutical composition containing N-chlorophenylcarbamates and N-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers
MXPA97007810A (es) Una composicion farmaceutica que contiene derivados de n-fosfonoglicina para inhibir el crecimientode virus y canceres

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued